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Abstract
Background:  Numerous  investigations  demonstrate  a  novel  role of thyroid hormone  as a
modulator of signal transduction. Protein kinase C (PKC) is critical to the mechanism by which
thyroid hormones potentiate both the antiviral and immunomodulatory actions of IFNγ  in different
cells and regulate the exchange of signalling phospholipids in hepatocytes. Because nothing is known
about accumulation of PKC modulator - diacylglycerol in cells treated with T4, we examined the
nongenomic effect of thyroid hormones on DAG formation and phospholipase activation in liver
cells.
Results:  The results obtained provide the first demonstration of phospholipase C, phospholipase
D and protein kinase C nongenomic activation and diacylglycerol (DAG) accumulation by L-T4 in
liver cells. The experiments were performed in either the [14C]CH3COOH-labeled rat liver slices
or isolated hepatocytes pre-labeled by [14C]oleic acid. L-T4 activates the DAG production in a
concentration- and time-dependent manner. DAG formation in stimulated cells is biphasic and
short-lived  event:  there  is  an  initial,  rapid  rise  in  DAG  concentration  and  then  a  slower
accumulation that can be sustained for a few minutes. The early phase of L-T4 generated DAG only
is  accompanied  by  phosphatidylinositol  4,5-bisphosphate  level  decrease  and  inositol  1,4,5-
trisphosphate  formation  while  the  second  phase  is  abolished  by  PKC  inhibitor  l,(5-
isoquinolinesulphonyl)2methylpiperasine dihydrochloride (H7) and propranolol. The second phase
of DAG production is accompanied by free choline release, phosphatidylcholine content drop and
phosphatidylethanol (Peth) formation. Inhibitor of phospholipase-C-dependent phosphoinositide
hydrolysis, neomycin sulfate, reduced the Peth as well as the DAG response to L-T4.
Conclusions:  The present data have indicated the DAG signaling in thyroid hormone-stimulated
liver cells. L-thyroxine activates a dual phospholipase pathway in a sequential and synchronized
manner: phospholipase C initiates  the DAG  formation, and PKC  mediates the integration of
phospholipase D into the signaling response during the sustained phase of agonist stimulation.
Background
Thyroid hormone exerts a broad range of effects on de-
velopment, growth and metabolism. The actions of thy-
roid hormone are primarily the result of their interaction
with nuclear receptors that bind to regulatory regions of
genes (thyroid hormone - response elements) and modi-
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fy their expression. Nuclear mechanisms of thyroid hor-
mone action have been extensively described [reviewed
in 1,2], but an increasing number of nogenomic effects of
the hormone at the cellular level have been recognized in
the past 10 years [reviewed in 3]. Nongenomic actions of
thyroid hormone are by definition independent on nu-
clear receptors for the hormone and have been described
at the plasma membrane, various organelles, the cy-
toskeleton, and in cytoplasm. The actions include altera-
tions in transport of Ca+2, Na+ and glucose; changes in
activities of several kinases, including protein kinase C
(PKC), cAMP -dependent protein kinase and mitogen -
activated protein kinase. Iodothyronines also can regu-
late nongenomically through a PKC activation of neutral
lipids, phospholipids [4] and phosphatidylinositol 4,5-
bisphosphate (PtdIns (4,5)P2) [5] synthesis in rat hepa-
tocytes. It has been determined that in HeLa cells poten-
tiation by thyroxine (T4) interferon -gamma - induced
antiviral state requires PKC and phospholipase C (PLC)
activities [6]. Direct evidence of the nongenomic PKC ac-
tivation by thyroid hormones has been found in rabbit
erythrocytes [7]. The regulation of PKC is critical to the
mechanism by which thyroid hormones rapidly induce
phosphorylation and nuclear translocation of mitogen-
activated protein kinase and subsequently potentiate
both the antiviral and immunomodulatory actions of
IFNγ  in cultured cells [8].
It is widely demonstrated on various cell types that inter-
action of Ca+2 - mobilizing hormones and transmitters
with the cell surface receptors leads to the phospholipid
breakdown under PLC or -D action and accumulation of
inosite phosphates and diacylglycerol (DAG). The regu-
latory molecules generation is accompanied by intracel-
lular free calcium concentration increase and, as a result,
by PKC activation.
An addition of the physiological doses of thyroid hor-
mones to the cell suspension rapidly increases the intra-
cellular calcium concentration in rat hepatocytes and
single rat heart cell [9,10]. On the other hand, there is no
information about accumulation of other PKC modulator
- DAG in the cells on T4 administration.
However, such genomic independent effect on the differ-
ent types of cells has been determined for steroid hor-
mones [11–13] whose mechanism of action on target cells
is known to be similar to that of the thyroid hormones.
In the present study, we have examined the nongenomic
effect of thyroid hormones on DAG formation and PKC
activation in liver cells. It was determined that L-T4 rap-
idly induces the biphasic DAG accumulation in liver slic-
es and isolated hepatocytes. The data obtained provide
evidence that L-T4 activates PLC and -D in sequential
manner that leads to increasing DAG formation during
sustained agonist stimulation. The L-T4-induced PLD -
PA phosphohydrolase (PAP) pathway of DAG generation
in rat hepatocytes is highly specific and PKC - dependent.
Figure 1
Effect of L-T4 on [ 14C]DAG and [14C]phospholipid
level  in  liver  slices  and  isolated  hepatocytes.
[14C] sodium ace tate  l abe led  liv er slice s (A) and [ 14C]oleic
a c i d  l a b e l e d  h e p a t o c y t e s  ( B )  w e r e  t r e a t e d  w i t h  1 0 0  n M
NaOH (control) or 10 nM L-T4 for indicated times. Lipids
were extracted, separated by TLC, and analyzed as described
in "Materials and Methods". Basal lipid levels in control cells
(Fig. 1B) did not change significantly over the experimental
period and were (cpm/107 cells): PI -4721 ±  633,  P I(4)P -
4265 ±  264, PI(4,5)P2 - 3605 ±  317, PC - 7662 ±  344, DAG -
6008 ±  106. Results represent the mean ±  S.E. of four individ-
ual experiments.* P < 0.05 vs. control.BMC Cell Biology (2001) 2:5 http://www.biomedcentral.com/1471-2121/2/5
Results and Discussion
This study was carried out to examine DAG formation
and degradation of phospholipids in rat liver cells treat-
ed with the thyroid hormones. It was demonstrated that
L-T4 induced a biphasic formation of DAG peaking at 15
sec and 1-2 min (Fig. 1A, B). Early phase was abolished
by neomycin sulfate, a specific inhibitor of phosphoi-
nositide hydrolysis (Table 1), and accompanied by Pt-
dIns(4,5)P2 level decrease (Fig. 1B). It has also been
shown that L-T4 stimulates inositol 1,4,5-trisphosphate
(Ins(l,4,5)P3) formations in [3H]inositol pre-labeled
hepatocytes. Basal and hormone-induced Ins(l,4,5)P3
levels in liver cells were 840+25 and 1832+42 cpm/107
cells, respectively (time of treatment: 0.25 min, n = 6, P
< 0.05).
Many cells produce DAG in a biphasic manner, involving
an initial and usually transient rise in DAG that is corre-
lated with phosphoinositide - specific PLC activation fol-
lowed by a sustained increase in DAG derived from
phosphatidylcholine (PC) hydrolysis [14].It is shown in
the present study that the second phase of DAG produc-
tion in liver slices (Fig. 1A) and isolated hepatocytes (Fig.
1B) coincided with hormone-stimulated PC content de-
crease. L-T4 - induced DAG formation in hepatocytes
was concentration-dependent and highly specific as D-
T4 failed to accumulate DAG (Fig. 2A). In rat hepato-
cytes, it has been reported that various regulatory factors
such as phorbol esters, guanine nucleotide-binding pro-
teins, hepatocyte growth factor, vasopressin and insulin
caused PC-dependent PLD activation and DAG forma-
tion [15–18]. PLD catalyzed hydrolytic cleavage of the
terminal diester bound of phospholipids, resulting in the
Table 1: Effect of neomycin sulfate and propranolol on the L-T4-induced DAG formation in [14]oleic acid pre-labeled hepatocytes.
Time, Additions Control L-thyroxine % of control
min
% total14C-lipids
NaOH 0.96 ±  0.11 1.34 ±  0.09* 140
0.25 NaOH+neomycin sulfate 1.43 ±  0.37 1.38 ±  0.04 96.7
NaOH 1.19 ±  0.06 2.02 ±  0.14* 170
2.0 NaOH+neomycin sulfate 1.08 ±  0.11 1.43 ±  0.09 132
NaOH+ propranolol 1.97 ±  0.21 1.77 ±  0.15 90
[14C]oleic acid labeled hepatocytes were pre-incubated for 15 min prior to NaOH (l00 nM) or LT4 (l0 nM) addition or pre-incubated for 15 min 
with neomycin sulfate (1.5 mM) or propranolol (100 nM) prior to stimulation with L-T4 (l0 nM).The data are mean ±  S.E. of four separate experi-
ments. * P < 0.05 vs. control.
Table 2: Effect of H7 on the L-T4-induced DAG and Peth formation in [14]oleic acid pre-labeled hepatocytes.
Lipid Additions Control L-T4 % of control
cpm/1 07 cells
NaOH+ethanol 2170 ±  362 5000 ±  638* 230
[14C]Peth
H7 + NaOH + ethanol 1847 ±  296 2915 ±  44* 158
NaOH 10797 ±  715 16515 ±  1077* 153
[14]DAG
H7+NaOH 7359 ±  746 9051 ±  1290 123
[14C]oleic acid labeled hepatocytes were pre-incubated for 15 min with H7 (50 µ M) or NaOH (l00 nM) alone prior to stimulation with L-T4 for 2 
min. 1.5% ethanol was added 15 min before L-T4 addition or together with H7 (50 µ M) or NaOH (100 nM) for determination of Peth formation in 
the cells. The data are mean ±  S.E. of four separate experiments. * P < 0.05 vs. control.BMC Cell Biology (2001) 2:5 http://www.biomedcentral.com/1471-2121/2/5
direct formation of PA and the respective base. The PA
produced can be converted to DAG by the action of PAP.
A unique property of PLD, which provides a specific as-
say for this enzyme, is the transphosphatidylation reac-
tion to generate the corresponding phosphatidylalcohol
in the presence of primary alcohol.
In the present study, to determine the PLD activity, the
formation of phosphatidylethanol (Peth) was measured
in intact (Fig. 2B) and [14C]oleic acid pre-labeled cells
(Table 2) in the presence of 1.5% ethanol. L-T4 stimula-
tory effect on Peth formation was specific and concentra-
tion-dependent (Fig. 2B). To determine if PC could be
the substrate for the PLD in L-T4 - stimulated cells the ef-
fect of hormone on isolated plasma membranes has been
investigated in the presence of [14C-methyl]PC (Fig. 3). It
was found that L-T4 rapidly stimulated [14C]PC degrada-
tion and free [14C]choline accumulation. Besides, L-T4
increased the level of choline in intact liver cells in a con-
centration -dependent manner (Fig. 2B). Early work [19]
has shown that L-T3 rapidly induced choline and PA ac-
cumulation in liver slices. To assess the possibility of PA
conversion to DAG in hormone-stimulated liver cells we
have used propranolol, which is known to block the con-
version of PA to DAG by inhibiting PAP. 100 nM pro-
pranolol was added 15 min prior to the hormone to
[14C]oleic acid pre-labeled cells. Propranolol completely
abolished L-T4 (10 nM for 2 min) stimulatory effect on
DAG accumulation (Table 1). Inhibitor of polyphosphoi-
nositide-specific PLC, neomycin sulfate, nullified the
first rise of DAG production and decreased the second
one in hormone stimulated cells. In rat hepatocytes,
commonly used PKC inhibitors, 1,(5- isoquino-
linesulphonyl)2methylpiperasine dihydrochloride (H7),
Ro31-8425 and calphostin C, inhibited HGF-, vaso-
pressin- and insulin -induced PC-specific PLD, suggest-
ing that PLD activity is regulated by PKC [16, 18].
Phorbol esters are highly effective stimuli of PLD activity
in intact cells [reviewed in 15]. The results presented
show that the pretreatment of [14C]-labeled hepatocytes
with protein kinase inhibitor - H7 decreased L-T4 effect
on [14C]Peth and [14C]DAG formation (Table 2). Pre-in-
cubation of liver cells with L-T4 leads to translocation of
PKC from cytosol to membrane fraction and its activa-
tion. D-T4 had no effect on enzyme activity of the frac-
tions investigated. The PKC activity in membranes
isolated from control (100 nM NaOH-treated cells) and
D-T4(10 nM)-treated hepatocytes was 1040 ±  111 and
865 ±  61 pmol/mg protein/min, respectively, and 1593 ±
167 and 937 ±  120 pmol/mg protein/min in cytosol of
control and hormone-treated cells, respectively. Howev-
er, the enzyme activity in L-T4-induced cells was 9498 ±
224 pmol/mg protein/min (for membrane; Pcontrol-L-T4
< 0,05, n = 4) and 633 ±  20 pmol/mg protein/min (for
cytosol).
Figure 2
Dose-dependent action of thyroid hormone on DAG
(A), choline and Peth (B) formation in hepatocytes.
[14C]oleic acid pre-labeled cells were treated with 100 nM
NaOH (control) or thyroid hormones for 2 min (A). The
DAG level in control cells: 4707 ±  544 cpm/107 cells. To
determine Peth formation in intact hepatocytes(B), 1.5% eth-
anol was added 15 min before hormone addition. Cells were
treated with hormones for 2 min. Reaction was stopped by
addition  of  ice-cold  methanol  to  the  culture  dishes.  Lipid
extraction was performed as described in [17]. Peth was sep-
arated by silica gel plates in a solvent system of upper phase
of  ethyl  acetate/2,2,4-trimethylpentane/acetic  acid/water
(13:2:3:10, v/v). The Peth area identified by co-migration with
Peth standard was scraped off the plates and the radioactivity
was determined by a liquid scintillation counter. The intensity
of the lipid spots was estimated by densitometry using a LKB
Ultroscan  laser  densitometer.  Free  choline  content  was
determined in intact control and hormone-treated cells by
the method described in [18]. Results are mean ±  S.E. of five
individual experiments. * P < 0.05 vs.control.BMC Cell Biology (2001) 2:5 http://www.biomedcentral.com/1471-2121/2/5
Conclusions
The investigations made indicate that in liver cells L-T4
rapidly stimulates the hydrolysis of polyphosphoi-
nositides by PLC with the resultant production of the
second messengers inositol triphosphate as well as DAG
and PKC activation. The major new finding of this study
was that in hepatocytes L-T4 stimulated PC cleavage by
PLD. As in the other cells, operated by Ca2+-mobilizing
receptors, PLD contributes to DAG formation in L-T4-
stimulated hepatocytes. DAG formed by PA breakdown
could further activate PKC in hormone-treated cells. In-
hibitor of PLC-dependent phosphoinostide hydrolysis,
neomycin sulfate, completely abolishes the first phase of
DAG production and reduces the PLD-dependent DAG
response to L-T4, indicating that PLD is activated during
the PLC-dependent signaling in liver cells. These data in-
dicate that L-T4 activates a dual phospholipase pathway
in a sequential and synchronized manner. PLC initiates
the increase in Ins(l,4,5)P3 and DAG formation and PKC
mediates integration of PLD into the signaling response
during the sustained phase of agonist stimulation. The
effect of L-T4 on PKC, PLD activation and DAG accumu-
lation is highly specific and too rapid (from seconds to a
few minutes) to be compatible with mRNA and protein
synthesis. These results provide the first evidence con-
cerning L-T4 nongenomic stimulation of phospholipid
hydrolysis by phospholipases and DAG accumulation in
liver slices and isolated hepatocytes.
Materials and Methods
Materials
[14C]oleic acid (58 mCi/mmol), myo- [3H]inositol (60
Ci/mmol) and [14C-methyl]phosphatidylcholine (58
mCi/mmol) - Amersham Corp., [γ -32P]ATP (l000 Ci/
mmol) and [14C]CH3COOH (25 mCi/mmol) - BPO Iso-
top (Russia); DEAE-52-cellulose from Whatman (Eng-
land); silica gel from Woelm
(Germany).Phosphatidylserine was isolated from ox
brain; other lipid standards, histone (typeIII), H7, pro-
pranolol and neomycin were obtained from Sigma
(USA). Other chemicals used were of chemically pure
grade.
Cell Suspension Experiments
Hepatocytes were isolated from the adult 90-day-old
male Wistar rats which had a free access to food and wa-
ter and were kept at 24° C on a cycle of 12 h light/12 h
darkness by the method described in [5]. Preparation of
hepatocytes was started between 9:00 and 10:00 a.m.
Cells (107/ml) were labeled by incubation in Eagle medi-
um containing 10% fetal calf serum, 100 units/liter
streptomycin, 100 units/liter penicillin, 13 mg/ml gen-
tamycin and 2.5 µ Ci/ml of [14C]oleic acid for 3 h in 95%
02/5% CO2 atmosphere at 37° C. Before hormones addi-
tion, cells were washed twice with a Krebs-Henseleit
buffer pH 7.4, containing 2 mM CaCl2, 25 mM HEPES,
0.1% BSA, and then preincubated at 37° C for 1 h. After
adding L-T4 or D-T4 or NaOH only to the cell suspension
(3 ×  106 cells/ml), the probes were incubated for differ-
ent periods. Reactions were stopped with ice-cold mix-
ture of chloroform and methanol (2:1, v/v). The PLD
activity in response to T4 was determined by measuring
the formation of Peth as was previously described [20].
The free choline content in intact cells was analyzed by
the method [21].
Experiments with Liver Slices
The 1 mCi of [14C]CH3COOH was intraperitoneally in-
jected four times every 30 minutes for 2 hours to rats
[21]. The liver was perfused with 0.9% NaCl, then re-
moved and washed in Krebs-Henseleit buffer, pH 7.4,
containing 2 mM CaCl2 and 0.2% BSA. Slices of liver
were preincubated in Krebs-Henseleit buffer for 10 min-
utes before hormones addition. Reaction was stopped
with ice-cold mixture of chloroform and methanol (2:1,
v/v). The lipids were extracted and analyzed as described
below.
Isolation and Incubation of Liver Cell Plasma Membranes
Plasma membranes were prepared using differential
centrifugation through various concentration of sucrose
and characterized by their specific marker enzymes as
described [22]. For PC hydrolysis, [14C-methyl]PC (0.25
µ Ci) was mixed with dipalmitoylphosphatidylcholine
Figure 3
Effect of L-T4 on [14C-methyl]PC metabolism in iso-
lated  liver  cell  plasma  membranes. [ 14C-methyl]PC
metabolism in isolated plasma membranes was investigated
as described in "Materials and Methods". Results are mean ±
S.E. of four individual experiments. * P < 0.05 vs. control.BMC Cell Biology (2001) 2:5 http://www.biomedcentral.com/1471-2121/2/5
suspended in 0.05% Triton X-100 (w/v) to 10 mM by
sonication and used as the substrate to give about 105
cpm/assay. Isolated plasma membranes were incubated
in medium (200 µ l) containing 50 mM sodium HEPES,
pH 7.5, 2 mM CaCl2, 3 mM MgCl2, 70 mM KCl and [14C-
methyl]PC at 37° C for the indicated time. The reaction
was terminated by adding of 200 µ l of 12.5% trichloro-
acetic acid (w/v) and 70 µ l of bovine serum albumin so-
lution (2 mg/ml). After vortexing and centrifugation at
12,000 g for 5 min the aqueous phase was separated and
the released 14C-labeled choline was analyzed by TLC.
The solvent system was: 0.5% NaCl/methanol/ethanol/
conc. NH4OH (50:20:30:5, v/v). The aqueous product
was identified by comparison with choline standard and
analyzed by scintillation counting. The [14C]lipids were
extracted and analyzed as described below.
Extraction and Separation of Lipids
Lipids were extracted according to Folch et al [23] and
phosphoinositides as described in [24]. The chloroform
phase was collected and dried under N2 at 37° C. The lip-
ids were redissolved in chloroform/methanol (1:2, v/v)
and applied on TLC plates. For isolation of DAG the sol-
vent system: hexane/diethyl ether/acetic acid (80:20:2,
v/v) was used; for PC separation -chloroform/methanol/
acetic acid/water (25:15:4:2, v/v) and for ItdIns(4,5)P2 -
chloroform/methanol/NH4OH (50:40:10, v/v). Appro-
priate standards were applied on each plate for quantifi-
cation. The gel spots containing lipids were scraped and
transferred to scintillation vials. Radioactivity was meas-
ured by scintillation counter.
[3H]Inositol Labeling of Hepatocytes and Determination 
of Inositol Phosphates Release in Stimulated Cells
Freshly isolated hepatocytes were plated in Petri dishes
(9 ×  106 cells/dish) in Williams E medium containing
10% fetal calf serum, 20 units/I penicillin, 13 mg/ml gen-
tamycin and 4 mg/ml dexametasone, 10 µ Ci myo-
[3H]inositol [25]. After 24-h incubation, the cells were
washed three times with inositol-free Williams E medi-
um, containing 0.1% BSA, then preincubated in the pres-
ence of 20 mM LiCl2 for 15 min, and incubated for 0.25
min in the presence of 0.1 µ M of L-T4. Reactions were
performed at 37° C and stopped at the indicated time by
removing the medium and washing three times with the
same inositol-free medium. The samples preparation
and inositol phosphates analysis were done as described
previously [24].
Protein kinase C Enzyme Assay
Activities of protein kinase C in the cytosol and in the
crude membrane fraction of hormone-treated (10 nM for
5 min) and control (100 nM NaOH) hepatocytes were de-
termined after partial purification of the enzyme by chro-
matography on DEAE-cellulose [26]. The activity of
protein kinase C was determined by the transfer of 32P
from [γ -32P]ATP into HI histone in the presence of phos-
phatidylserine and Ca2+ (0.2 mM).This approach meas-
ures all the isoforms of PKC. The enzyme activity was
expressed as pmoles of phosphate transferred from [γ -
32P]ATP into HI histone per minute. The protein content
was determined by the method of Bradford [27].
Abbreviations
T4 - thyroxine, PKC - protein kinase C, PtdIns(4,5)P2 -
phosphatidylinositol 4,5-bisphosphate, PLC - phosphol-
ipase C, PLD - phospholipase D, DAG - diacylglycerol, PA
- phosphatidic acid, PC -phosphatidylcholine,
Ins(l,4,5)P3 - inositol 1,4,5- trisphosphate, Peth - phos-
phatidylethanol.
References
1. Brent GA, More DD, Larsen PR: Thyroid hormone regulation of
gene expression. Annu Rev Physiol 1991, 53:17-35
2. Laser MA: Thyroid hormone receptors: multiple forms, mul-
tiple possibilities. Endocr Rev 1993, 14:184-193
3. Davis PJ, Davis FB: Nongenomic action of thyroid hormone.
Thyroid 1996, 16:497-504
4. Babenko NA, Kavok NS: Effect of thyroid hormones, phorbol
esters, and sphingosine on the incorporation of linoleic acid
into lipids in the liver of white rats. Biokhimiya 1995, 60:1545-
1550
5. Krasilnikova OA, Babenko NA: Role of thyroid hormones in reg-
ulation  of  phosphatidic  acid,  phosphatidylinositole,  and
polyphosphoinositide synthesis in liver cells. Biokhimiya 1996,
61:1008-1014
6. Lin HY, Thacorf HR, Davis FB, Davis PJ: Potentiation by thyroxine
of interferon-gamma-induced antiviral state requires PKA
and PKC activities. Am J Physiol 1996, 271(4 Pt1):C1256-C1261
7. Lawrence WD, Schoenl M, Davis PJ: Stimulation in vitro of rabbit
erythrocyte cytosol phospholipid-dependent protein kinase
activity. A novel action of thyroid hormone. J Biol Chem 1989,
264(9):4766-4768
8. Lin HY, Davis FB, Gordinier JK, Martino LJ, Davis PJ:  Thyroid hor-
mone induces activation of mitogen-activated protein kinase
in cultured cells. Am J Physiol 2000, 276(5Pt1):1014-1024
9. Hummerich H, Soboll S: Rapid stimulation of calcium uptake
into rat liver by L-triiodothyronine. Biochem J 1989, 258:363-367
10. Lamax RB, Gobbold PH, Cuthbertson KSR, Robertson WR: Acute
effects of thyroid hormones on cytoplasmic [Ca2+] in single
rat heart cells. J Endocrinol 1989, 121:57-
11. Facchinetti M, de Boland AR: Calcitriol transmembrane signal-
ing regulation of rat muscle phospholipase D activity. J Lipid
Research 1998, 39:197-204
12. Tien X-Y, Brasitus TA, Qasawa BN, Norman AW, Sitrin MD: Effect
of 1,25(OH)2D3 and its analogues on membrane phosphoi-
nositide turnover and [Ca2+] in Caco-2 cells. Am J Physiol 1993,
265:G143-G148
13. Beno DWA, Brady LM, Bissonnette M, Davis BH: Protein kinase C
and mitogen-activated protein kinase are required for 1,25-
dihydroxyvitamin  D3-stimulated  Egr  induction.  J  Biol  Chem
1995, 270:3642-3647
14. Nishizuka Y: Intracellular signaling by hidrolisis of phospholip-
ids and activation of protein kinase C. Science 1992, 258:607-
614
15. Exton JH: Phosphatidylcholine breakdown and signal trans-
duction. Biochim Biophys Acta 1994, 1212:26-42
16. Gustavsson L, Moehren G, Torres-Marqez ME, Benistant C, Rubin R,
Hoek JB: The role of cytosolic Ca2+, protein kinase C and pro-
tein kinase A in hormonal stimulation of phospholipase D in
rat hepatocytes. J Biol Chem 1994, 269:849-859
17. Donchenko JB, Zannetti A, Baldini PM: Insulin-stimulated hydrol-
ysis  of  phosphatidylcholine  by  phospholipase  C  and  phos-
pholipase D in cultured rat hepatocytes. Biochim Biophys Acta
1994, 1222:492-500BMC Cell Biology (2001) 2:5 http://www.biomedcentral.com/1471-2121/2/5
18. Adachi T, Nakashima S, Saji S, Nakamura T, Nozawa Y: Phospholi-
pase D activation in growth factor-stimulated rat hepato-
c y t e s  m e d i a t e s  t h e  e x p r e s s i o n s  o f  c - j u n  a n d  c - f o c :
involvement of protein tyrosine kinase, protein kinase C, and
Ca2+ Hepatology 1996, 24:1274-1281
19. Babenko NA, Phylonenko NS, Viliyasenor VZ, Nikitin VN: Thyroid
hormones stimulate the phospholipase D activity in hepato-
cytes of rats of different age and thyroid state. Reports USSR
Acad Sci 1991, 320:745-748
20. Kumada T, Miyata H, Nozawa Y: Involvement of tyrosine phos-
phorylation in IgE receptor-mediated phospholipase D acti-
vation  in  rat  basophilic  leukemia  (RBL-2H3)  cells.  Biochem
Biophys Res Commun 1993, 191:1363-1368
21. Kates M: Techniques of lipidology: Isolation, analysis and iden-
tification of lipids. New York: American Elsevier Publishing Company
1972, 
22. Provost JJ, Fudge J, Isaraelit S, Siddiqi AR, Exton JH:  Tissue and sub-
cellular  distribution  of  phospholipase  D.  Biochem  J  1996,
319:285-291
23. Folch J, Lees M, Stanley GHS: A simple method for the isolation
and purification of total lipid from animal tissues. J Biochem
1957, 226:497-509
24. Andrews WV, Conn PM: Measurement of inositol phospholipid
metabolites by one-dimensional thin-layer chromatography.
I n  M e t h o d s  i n  E n z y m o l o g y .  N e w  Y o r k :  A c a d e m i c  P r e s s ,  I n c .   1987,
141:156-168
25. Jones MJ, Murray W: Evidence that ceramide selectively inhib-
its protein kinase C-α  tranclocation and modulates bradyki-
nin activation of phospholipase D. J Biol Chem 1995, 270:5007-
5013
26. Kikawa U, Takai Y, Minakuchi R, mohara S, Nishizuka Y: Calcium-
activated,  phospholipid-dependent  protein  kinase  of  rat
brain. Subcellular distribution, purification and properties. J
Biol Chem 1982, 257:13341-13348
27. Bradford M: A rapid sensitive method for the quantitation of
microgram  quantities  of  protein  utilizing  the  principle  of
protein dye binding. Anal Biochem 1972, 72:248-254
Publish with BioMedcentral and every 
scientist can read your work free of charge
"BioMedcentral will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Paul Nurse, Director-General, Imperial Cancer Research Fund
Publish with BMc and your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours - you keep the copyright
editorial@biomedcentral.com
Submit your manuscript here:
http://www.biomedcentral.com/manuscript/
BioMedcentral.com BioMedcentral.com